Tag: ALTUS study
-
Liver Cancer Early Detection Gets a Boost from ALTUS Blood Test Study
Groundbreaking ALTUS Study Highlights Blood-Based Liver Cancer Detection Exact Sciences Corp. today announced pivotal validation results from the ALTUS study (NCT: 05064553), a prospective, head-to-head evaluation of a blood-based surveillance test for liver cancer detection. The findings, presented by the company in Madison, Wisconsin, suggest clear improvements in identifying liver cancer at an earlier, more…
-
Exact Sciences Unveils Breakthrough Blood Test for Early Liver Cancer Detection
Groundbreaking Validation of a Blood-Based Liver Cancer Screening Tool Exact Sciences Corp. has announced pivotal clinical validation results from the ALTUS study, a prospective, head-to-head evaluation designed to assess a blood-based surveillance test for liver cancer. Conducted in a real-world, high-risk population, the ALTUS study (NCT: 05064553) represents a major step toward accessible, non-invasive screening…
-
Exact Sciences Unveils Breakthrough: Blood-Based Test Boosts Early Liver Cancer Detection
Breakthrough in Liver Cancer Detection Exact Sciences Corp. announced pivotal clinical validation results from the ALTUS study, signaling a major step forward in the early detection of liver cancer through a blood-based surveillance test. The prospective, head-to-head study (NCT: 05064553) evaluated the test’s performance against existing screening modalities, with results indicating superior sensitivity and specificity…